Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 291

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double‐blind, placebo‐controlled randomized trial

Open access
Kline, J.A., Nordenholz, K.E., Courtney, D.M., Kabrhel, C., Jones, A.E., Rondina, M.T., Diercks, D.B., Klinger, J.R., Hernandez, J.·2014·Journal of Thrombosis and Haemostasis

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jth.12521

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 32

  1. Jaff, 2011, Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association, Circulation, 1, 1788, 10.1161/CIR.0b013e318214914f · DOI · Paper page
  2. Torbicki, 2008, Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC), Eur Heart J, 29, 2276, 10.1093/eurheartj/ehn310 · DOI · Paper page
  3. Holbrook, 2012, Evidence‐based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines, Chest, 141, e152S, 10.1378/chest.11-2295 · DOI · Paper page
  4. Worster, 2007, Evidence‐based emergency medicine/critically appraised topic. Thrombolytic therapy for submassive pulmonary embolism?, Ann Emerg Med, 50, 78, 10.1016/j.annemergmed.2007.01.002 · DOI
  5. Dong, 2009, Thrombolytic therapy for pulmonary embolism, Cochrane Database Syst Rev, CD004437
  6. Pollack, 2011, Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry), J Am Coll Cardiol, 57, 700, 10.1016/j.jacc.2010.05.071 · DOI · Paper page
  7. Stein, 2012, Trends in case fatality rate in pulmonary embolism according to stability and treatment, Thromb Res, 130, 841, 10.1016/j.thromres.2012.07.011 · DOI
  8. 2012, Am Heart J, 163, 33, 10.1016/j.ahj.2011.10.003 · DOI
  9. Kline, 2013, Rationale and methodology for a multicentre randomised trial of fibrinolysis for pulmonary embolism that includes quality of life outcomes, Emerg Med Australas, 25, 515, 10.1111/1742-6723.12159 · doi:10.1111/1742-6723.12159
  10. Klok, 2010, Quality of life in long‐term survivors of acute pulmonary embolism, Chest, 138, 1432, 10.1378/chest.09-2482 · DOI · Paper page
  11. Klok, 2010, Prevalence and potential determinants of exertional dyspnea after acute pulmonary embolism, Respir Med, 104, 1744, 10.1016/j.rmed.2010.06.006 · DOI
  12. Klok, 2008, Persistent dyspnea complaints at long‐term follow‐up after an episode of acute pulmonary embolism: results of a questionnaire, Eur J Intern Med, 19, 625, 10.1016/j.ejim.2008.02.006 · DOI
  13. Kline, 2009, Prospective evaluation of right ventricular function and functional status six months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure, Chest, 136, 1202, 10.1378/chest.08-2988 · DOI
  14. Fasullo, 2011, Six‐month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin, Am J Med Sci, 341, 33, 10.1097/MAJ.0b013e3181f1fc3e · DOI
  15. Sharifi, 2013, Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” Trial), Am J Cardiol, 111, 273, 10.1016/j.amjcard.2012.09.027 · DOI · Paper page
  16. Otero, 2011, Echocardiographic assessment of pulmonary arterial pressure in the follow‐up of patients with pulmonary embolism, Thromb Res, 127, 303, 10.1016/j.thromres.2010.12.010 · DOI
  17. Kahn, 2008, Physical activity in patients with deep venous thrombosis: a systematic review, Thromb Res, 122, 763, 10.1016/j.thromres.2007.10.011 · DOI
  18. Vazquez, 2009, Contemporary issues in the prevention and management of postthrombotic syndrome, Ann Pharmacother, 43, 1824, 10.1345/aph.1M185 · DOI
  19. Kline, 2006, Surrogate markers for adverse outcomes in normotensive patients with pulmonary embolism, Crit Care Med, 34, 2773, 10.1097/01.CCM.0000241154.55444.63 · DOI
  20. Kubo, 2004, Development and validation of a patient questionnaire to determine New York Heart Association classification, J Card Fail, 10, 228, 10.1016/j.cardfail.2003.10.005 · DOI
  21. Hays, 1993, The Rand 36‐item health survey 1.0, Health Econ, 2, 217, 10.1002/hec.4730020305 · DOI · Paper page
  22. Kahn, 2006, VEINES‐QOL/Sym questionnaire was a reliable and valid disease‐specific quality of life measure for deep venous thrombosis, J Clin Epidemiol, 59, 1049, 10.1016/j.jclinepi.2005.10.016 · DOI · Paper page
  23. Stevinson, 2007, Echocardiographic and functional cardiopulmonary problems 6 months after first‐time pulmonary embolism in previously healthy patients, Eur Heart J, 28, 2517, 10.1093/eurheartj/ehm295 · DOI · Paper page
  24. Becattini, 2010, Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism, Thromb Res, 125, e82, 10.1016/j.thromres.2009.09.017 · DOI · Paper page
  25. Erkens, 2010, Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism, Cochrane Database Syst Rev, CD001100
  26. van Es, 2013, Quality of life after pulmonary embolism as assessed with SF‐36 and PEmb‐QoL, Thromb Res, 132, 500, 10.1016/j.thromres.2013.06.016 · DOI
  27. Nieto, 2013, Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism, Thromb Res, 132, 175, 10.1016/j.thromres.2013.06.019 · DOI
  28. Montori, 2005, Randomized trials stopped early for benefit: a systematic review, JAMA, 294, 2203, 10.1001/jama.294.17.2203 · DOI · Paper page
  29. Sharma, 2000, Long‐term benefit of thrombolytic therapy in patients with pulmonary embolism, Vascular Medicine, 5, 91, 10.1177/1358836X0000500205 · DOI
  30. Lewis, 2013, Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases, Circulation, 128, 1470, 10.1161/CIRCULATIONAHA.112.000667 · DOI · Paper page
  31. Puhan, 2007, Relative responsiveness of the Chronic Respiratory Questionnaire, St. Georges Respiratory Questionnaire and four other health‐related quality of life instruments for patients with chronic lung disease, Respir Med, 101, 308, 10.1016/j.rmed.2006.04.023 · DOI
  32. Penaloza, 2012, European and American suspected and confirmed pulmonary embolism populations: comparison and analysis, J Thromb Haemost, 10, 375, 10.1111/j.1538-7836.2012.04631.x · DOI

Cited by

See all 291

Metadata

Authors
Kline, J. A., Nordenholz, K. E., Courtney, D. M., Kabrhel, C., Jones, A. E., Rondina, M. T., Diercks, D. B., Klinger, J. R., & Hernandez, J.
Venue
Journal of Thrombosis and Haemostasis
Publisher
Elsevier BV
Published
2014-04
Volume
12
Issue
4
Pages
459-468
ISSN
1538-7836 (ISSN-L)
OpenAlex
W1978243757
Cited by
291
References
3
FWCI
23.12
Type
journal article
Language
en
Open access
bronze
Licence
Funders
  • Genentech, Inc
  • National Institutes of Health
  • Radiometer, Alere, DOD

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double‐blind, placebo‐controlled randomized trial. https://app.cochat.ai/papers/10.1111/jth.12521
The paper
Kline, J. A., Nordenholz, K. E., Courtney, D. M., Kabrhel, C., Jones, A. E., Rondina, M. T., Diercks, D. B., Klinger, J. R., & Hernandez, J. (2014). Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double‐blind, placebo‐controlled randomized trial. Journal of Thrombosis and Haemostasis. https://doi.org/10.1111/jth.12521

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.